Lv21
200 积分 2025-12-15 加入
Orforglipron: First Approval
2个月前
已完结
THU0055 ANTI-DEGRADATIVE AND PRO-CHONDROGENIC PROPERTIES OF LIRAGLUTIDE, A GLUCAGON-LIKE-PEPTIDE 1 RECEPTOR AGONIST: EVIDENCE FROM PRECLINICAL STUDIES AND IMPLICATION FOR OSTEOARTHRITIS
2个月前
已关闭
Protective effects of intra-articular formulated liraglutide in osteoarthritis : preclinical studies
2个月前
已完结
Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment
6个月前
已完结
Delivering living medicines with biomaterials
7个月前
已完结
Osteoarthritis: pathogenic signaling pathways and therapeutic targets
9个月前
已完结
Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy
10个月前
已完结
皖公网安备34019202002308
